Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-044046
Filing Date
2022-02-16
Accepted
2022-02-16 09:04:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d300563d424b3.htm 424B3 23700
2 GRAPHIC g300563g0216061125928.jpg GRAPHIC 6608
  Complete submission text file 0001193125-22-044046.txt   34031
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 22641639
SIC: 2834 Pharmaceutical Preparations